Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Caribou Biosciences Inc (NASDAQ: CRBU) closed at $1.01 up 2.49% from its previous closing price of $0.99. In other words, the price has increased by $2.49 from its previous closing price. On the day, 0.74 million shares were traded. CRBU stock price reached its highest trading level at $1.03 during the session, while it also had its lowest trading level at $1.0.
Ratios:
For a deeper understanding of Caribou Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.16 and its Current Ratio is at 7.16. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on June 03, 2024, Downgraded its rating to In-line and sets its target price to $3 from $13 previously.
On October 31, 2023, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $13.Evercore ISI initiated its Outperform rating on October 31, 2023, with a $13 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 21 ’25 when MCCLUNG BARBARA G sold 3,564 shares for $1.35 per share. The transaction valued at 4,811 led to the insider holds 443,502 shares of the business.
Khan Ruhi Ahmad sold 3,564 shares of CRBU for $4,811 on Feb 21 ’25. The Chief Business Officer now owns 66,936 shares after completing the transaction at $1.35 per share. On Feb 21 ’25, another insider, Kanner Steven, who serves as the Chief Scientific Officer of the company, sold 3,564 shares for $1.35 each. As a result, the insider received 4,811 and left with 431,556 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRBU now has a Market Capitalization of 93934648 and an Enterprise Value of -89115352. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.40 while its Price-to-Book (P/B) ratio in mrq is 0.37. Its current Enterprise Value per Revenue stands at -8.917 whereas that against EBITDA is 0.563.
Stock Price History:
The Beta on a monthly basis for CRBU is 2.29, which has changed by -0.80669856 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, CRBU has reached a high of $5.94, while it has fallen to a 52-week low of $0.98. The 50-Day Moving Average of the stock is -26.71%, while the 200-Day Moving Average is calculated to be -45.99%.
Shares Statistics:
For the past three months, CRBU has traded an average of 1.33M shares per day and 947610 over the past ten days. A total of 92.38M shares are outstanding, with a floating share count of 80.81M. Insiders hold about 13.11% of the company’s shares, while institutions hold 58.75% stake in the company. Shares short for CRBU as of 1740700800 were 10220575 with a Short Ratio of 7.70, compared to 1738281600 on 8858817. Therefore, it implies a Short% of Shares Outstanding of 10220575 and a Short% of Float of 11.83.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
